Who Paid My Doc Search
Menu
Organisation paid for research Program year 2023 Source: CMS Open Payments

Elixia Research

Neither a doctor nor a teaching hospital

Research payments

$1,051,371

38 payments

Through program year 2023, Elixia Research is reported as receiving $1,051,371 in research payments, across 38 payments.

By program year

2 rows
Year Kind Amount Payments
2023 Research $1,025,082 3
2021 Research $26,289 35

Breakdown

Who paid Research payments · program years 2021–2023
  1. Boehringer Ingelheim Pharmaceuticals, Inc. $1,027,312 4 payments
  2. Boehringer Ingelheim Canada Ltd.Ltee $24,059 34 payments
Studies the money was for Research payments · program years 2021–2023
  1. Phase II dose finding PoCC in CKD $1,025,082 3 payments
  2. BI 767551 (EX14870) Ph II/III SARS-COV-2 Ambulatory Pts IV $24,059 34 payments
  3. BI 767551 EX 14870 Ph III in SARS Cov 2 Preventi $2,230 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2023

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record